We pioneered the development of a non-viral cell-engineering platform more than 16 years ago for the delivery of biomolecules that fulfills the stringent demands of clinical use – namely the ability to safely and reproducibly modify primary human cells with high efficiency, low cytotoxicity, and at the scale required to treat patients. Today, our delivery platform is making cell and gene therapy a reality.
Dendritic cell loading
Stem cell engineering
Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter